| | |

How Do We Know If the Treatment is Working? Measuring Malignant Pleural Mesothelioma Treatment Response

ByHolly Zink

Measuring Treatment Response for Malignant Pleural Mesothelioma Malignant pleural mesothelioma is a rare type of cancer. A growing number of mesotheliomas are being treated with novel immunotherapies. But clinicians still lack a meaningful way to measure mesothelioma treatment response.

An article in Seminars in Nuclear Medicine lists five ways clinicians can measure how well a treatment plan is working. And a new artificial intelligence tool can measure mesothelioma tumors without any human input. Artificial intelligence may provide the key to treatment response in the future.

Measuring Mesothelioma Treatment Response

In malignant pleural mesothelioma, complex tumors result in inconsistent clinical assessment. There are five common ways to measure if a treatment plan is working. Generally, a clinician will look to see if the size or weight of a tumor has changed after treatment.

The first is: Response Evaluation Criteria In Solid Tumors (RECIST). It has been the main choice for objective treatment response assessment in clinical trials. But, this response assessment was designed for tumors with a spherical shape, which is not mesothelioma. Malignant pleural mesothelioma has a different shape and growth pattern. This makes it difficult to use RECIST measurement for mesothelioma.

The second is: mRECIST (modified Response Evaluation Criteria In Solid Tumors). This option works better for malignant pleural mesothelioma. This measurement focuses more on the thickness of a tumor, rather than its shape or diameter.

The third introduces immunotherapy to the first and second choices: iRECIST/imRECIST/iRC. Immunotherapy treatments are common. But they lead to problems with the conventional treatment assessments. Immunotherapy causes the shape and size of a tumor to change during treatment. This third option adjusts the treatment assessment based on immunotherapy factors.

The fourth choice is: EORTC/PERCIST. That’s the European Organization for Research and Treatment of Cancer (EORTC). And the PET Response Criteria in Solid Tumors (PERCIST). This method uses imaging and scans to track if a treatment is working. PET/CT scans are most common. This method is a quicker assessment than the other options. Clinicians can get results sooner after starting therapy. This method has not yet been validated in a clinical trial.

The fifth choice is Volumetric Response Assessment. This method compares the weight and measurement of a tumor to assess treatment success. But, again, the growth pattern of malignant pleural mesothelioma can make this difficult.

Machine Learning to Support Measurement of Treatment Response

Some have looked at using machine learning to help with this problem. Machine learning has been used to look at mesothelioma type and genomic data. But no one has used machine learning with medical imaging to assess treatment response.

The German team is looking to apply new machine learning techniques to assess mesothelioma treatment response.

The team thinks that artificial intelligence could enable better measurement of malignant pleural mesothelioma tumor volume. This will help measure how well a treatment plan is working. And it will also help clinicians come to a quicker diagnosis. This tool’s performance may be further improved with more training and calibration.

Source:

Sandach, Patrick, Robert Seifert, Wolfgang P. Fendler, Hubertus Hautzel, Ken Herrmann, Sandra Maier, Till Plönes, Martin Metzenmacher, and Justin Ferdinandus. “A Role for PET/CT in response assessment of malignant pleural mesothelioma.” In Seminars in Nuclear Medicine. WB Saunders, 2022. https://doi.org/10.1053/j.semnuclmed.2022.04.008

 

Similar Posts

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma
| |

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

ByAlex Strauss

A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

Mesothelioma Still Rising Despite Ban in Ireland
|

Mesothelioma Still Rising Despite Ban in Ireland

ByAlex Strauss

A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Radiotherapy for Mesothelioma: Better But Still Limited
| |

Radiotherapy for Mesothelioma: Better But Still Limited

ByAlex Strauss

A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

Mesothelioma Nurses Ready for New Cases in Australia
| | |

Mesothelioma Nurses Ready for New Cases in Australia

ByAlex Strauss

Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…